[1] 刘梦思,王倩,景玳慧. 儿童医院呼吸道感染患儿流感嗜血杆菌感染情况与耐药性分析[J]. 青岛医药卫生,2019,51(5):397-400. DOI:10.3969/j.issn.1006-5571.2019.05.023.
[2] 蒋小丽,李阳超,刘滔,等. 某地区流感嗜血杆菌感染现状及耐药性变迁分析[J]. 检验医学与临床,2019,16(23):3481-3483. DOI:10.3969/j.issn.1672-9455.2019.23.027.
[3] 曹忠海. 流感嗜血杆菌感染的致病菌变迁和耐药趋势研究[J/CD]. 世界最新医学信息文摘(连续型电子期刊),2020,20(83):361-362. DOI:10.3969/j.issn.1671-3141.2020.83.178.
[4] 沈莹. 儿童医院呼吸道感染患儿流感嗜血杆菌感染情况与耐药性分析[J]. 基层医学论坛,2020,24(17):2423-2424. DOI:10.19435/j.1672-1721.2020.17.033.
[5] 高雪,吴玲玲,伦恒忠. 泰安地区儿童流感嗜血杆菌感染耐药性分析[J]. 泰山医学院学报,2021,42(3):210-213. DOI:10.3969/j.issn.1004-7115.2021.03.012.
[6] 许丽娜,白云. 儿童流感嗜血杆菌感染分布及耐药性监测分析[J]. 临床研究,2021,29(8):135-136.
[7] 中华医学会儿科学分会感染学组,中国儿童感染性疾病病原学及细菌耐药监测协作组,中华儿科杂志编辑委员会. 儿童流感嗜血杆菌感染诊断及治疗专家建议[J]. 中华儿科杂志,2019,57(9):663-668. DOI:10.3760/cma.j.issn.0578- 1310.2019.09.004.
[8] 王高良,华春珍,杨林海,等. 2014—2018年儿童侵袭性流感嗜血杆菌感染84例临床特点分析[J]. 中华儿科杂志,2019,57(8):592-596. DOI:10.3760/cma.j.issn.0578‐1310. 2019.08.004.
[9] 易秋维. 儿童侵袭性流感嗜血杆菌诊疗情况分析[J/CD]. 临床医药文献电子杂志,2019,6(78):10,12.DOI:10.16281/j.cnki.jocml.2019.78.008.
[10] 魏红霞,孙曹玮. 55例侵袭性流感嗜血杆菌感染患儿的流行病学特征及其耐药性分析[J]. 抗感染药学,2022,19(4):552-554. DOI:10.13493/j.issn.1672-7878.2022.04-025.
[11] 王雪宁,朱巧棉. 侵袭性流感嗜血杆菌感染患儿的临床特征及预后分析[J]. 临床医学研究与实践,2023,8(19):44-47.DOI:10.19347/j.cnki.2096-1413.202319011.
[12] Ulanova M, Tsang RS, Goldfarb DM, et al. Prevalence of Haemophilus influenzae in the nasopharynx of children from regions with varying incidence of invasive H. Influenzae serotype a disease: Canadian Immunization Research Network (CIRN) study[J].Int J Circumpolar Health, 2024,83(1):2371111. DOI:10.1080/22423982.2024.2371111.
[13] 叶蕊,周玉红,赵雪,等. 2018-2021年某院流感嗜血杆菌感染分布及耐药性[J]. 检验医学与临床,2022,19(21):2916-2921. DOI:
[14] 胡莹,陈群英,马巧红,等. 宁波市某医院儿童流感嗜血杆菌感染临床特征和耐药性分析[J]. 中国消毒学杂志,2023,40(4):269-271. DOI:10.11726/j.issn.1001-7658. 2023.04.009.
[15] 骆晓凤,朱叶飞,赵水娣,等. 呼吸道及非呼吸道流感嗜血杆菌感染特征及耐药性分析[J]. 检验医学与临床,2021,18(9):1231-1234. DOI:10.3969/j.issn.1672-9455.2021.09.013.
[16] 孟晋华,李文玲,孙志勇,等. 儿童侵袭性流感嗜血杆菌感染的临床特征及血清学分型[J]. 中国感染控制杂志,2024,23(6):700-705. DOI:10.12138/j.issn.1671-9638. 20245007.
[17] Brueggemann AB, Jansen van Rensburg MJ, Shaw D, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data[J]. Lancet Digit Health, 2021,3(7):413.DOI:10.1016/S2589-7500(21)00103-5.
[18] Wen S, Feng D, Chen D, et al. Molecular epidemiology and evolution of Haemophilus influenzae[J].Infect Genet Evol, 2020,80:104205. DOI:10.1016/j.meegid.2020.104205.
[19] Slack MPE, Cripps AW, Grimwood K, et al. Invasive Haemophilus influenzae infections after 3 decades of Hib protein conjugate vaccine use[J].Clin Microbiol Rev, 2021,34(3):0002821. DOI:10.1128/CMR.00028-21.
[20] Ma C, Zhang Y, Wang H. Characteristics of Haemophilus influenzae carriage among healthy children in China: a meta-analysis[J].Medicine (Baltimore), 2023,102(44):35313. DOI:10.1097/MD.0000000000035313
[21] Brown NE, Blain AE, Burzlaff K, et al. Racial Disparities in Invasive Haemophilus influenzae Disease-United States, 2008-2017[J].Clin Infect Dis, 2021,73(9):1617-1624. DOI:10.1093/cid/ciab449.
[22] 黄凤,顾文婧,蒋吴君,等. 苏州地区流感嗜血杆菌感染与环境气候的相关因素分析[J]. 中国当代儿科杂志,2022,24(12):1351-1355.DOI:10.7499/j.issn.1008-8830. 2205051.
[23] Deghmane AE, Taha MK. Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic[J].Microorganisms, 2022,10(5):907.DOI:10.3390/microorganisms10050907.
[24] Zulz T, Huang G, Rudolph K, et al. Epidemiology of invasive Haemophilus influenzae serotype a disease in the North American Arctic, 2006-2017[J].Int J Circumpolar Health, 2022,81(1):2150382. DOI:10.1080/22423982.2022.2150382.
[25] Hani E, Abdullahi F, Bertran M, et al. Trends in invasive Haemophilus influenzae serotype b (Hib) disease in England: 2012/13 to 2022/23[J].J Infect, 2024,89(4):106247. DOI:10.1016/j.jinf.2024.106247
|